Prognostic effect of weight loss prior tochemotherapy in cancer patients

The American Journal of Medicine

Volumn 69, Issue 4, 1980, Pages 491-497

  Dewys, William D ^a   Begg, Colin ^a   Lavin, Philip T ^a   Band, Pierre R ^a   Bennett, John M ^a   Bertino, Joseph R ^a   Cohen, Martin H ^a   Douglass Jr , Harold O ^a   Engstrom, Paul F ^a   Ezdinli, Ediz Z ^a   Horton, John ^a   Johnson, Gerhard J ^a   Moertel, Charles G ^a   Oken, Martin M ^a   Perlia, Charles ^a   Rosenbaum, Charles ^a   Silverstein, Murray N ^a   Skeel, Roland T ^a   Sponzo, Robert W ^a   Tormey, Douglass C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; PREDNISONE; PROCARBAZINE; SEMUSTINE; STREPTOZOCIN; TESTOLACTONE; TIOGUANINE; VINCRISTINE;

BODY WEIGHT; CANCER; CANCER CHEMOTHERAPY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PROGNOSIS; SURVIVAL; THERAPY;

ACTIVITIES OF DAILY LIVING; BODY WEIGHT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS;

EID: 0018949428     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-2918(05)80001-3     Document Type: Article

References (38)

1. Keynote address on biostatistics and data retrieval
2. Nutrition as an adjuvant to cancer treatment in the adult
3. Cancer chemotherapeutic response and intravenous hyperalimentation
4. Results of a E.O.R.T.C. randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: Prognostic factors and treatment results
5. Survival with inoperable lung cancer-integration of prognostic variables based on simple clinical criteria
6. Prognostic factors in 454 cases of Hodgkin's disease
7. Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults
8. Adriamycin and cytoxan in the treatment in inoperable lung cancer (abstract)
9. Chemotherapy of disseminated breast cancer. Current status and prospects
10. Induction chemotherapy and maintenance chemo-hormonotherapy in metastatic breast cancer (abstract)
11. Comparison of adriamycin (ADRIA) and 5-fluorouracil (5FU) in advanced prostatic cancer (abstract)
12. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or6-thioguanine, with intravenous 5-fluorouracil or beta-2′-deoxy-thioguanosine or with oral 3 4-methyl-cyclohexyl-1 2-chlorethyl-l-nitrosourea. A phase II–III study of the Eastern Cooperative Oncology Group (EST 4273)
13. Treatment of advanced soft tissue sarcoma
14. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group Experience
15. Chemotherapy of prognostically favorable non-Hodgkin's lymphomas (abstract)
16. Eastern Cooperative Oncology Group experience with the Rappaport classification of non-Hodgkin's lymphomas
17. Cyclophosphamide (C), vincristine (V), and prednisone (P) plus adriamycin (A), bleomycin (B) or BCNU: a prospective clin ical trial in unfavorable diffuse non-Hodgkin's lymphoma (NHL) (abstract)
18. The value of adriamycin and of mid-cycle treatment in multidrug therapy of unfavorable histology non-Hodgkin's lymphoma (abstract)
19. Non-Hodgkin's lymphoma (NHL): effect of histologic subtype on toxicity and response to chemother apy
20. Chemotherapy of gastric and pancreatic carcinoma—A controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and “lactones”
21. Evaluation of survival data and two new rank order statistics arising in its consideration
22. Nonparametric estimation from incomplete observations
23. Principles of nutritional care of the cancer patient
24. Anorexia as a general effect of cancer
25. Skeletal muscle metabolism in patients with malignant tumor
26. Energy balance and body composition in cancer patients
27. Metabolic observations during forced feeding of patients with cancer
28. Abnormalities of taste sensation in cancer patients
29. Energy and nitrogen metabolism in cancer
30. Densitometric analysis of body composition: Revision of some quantitative assumptions
31. Treatment of acute leukemia
32. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state andsensitivity to cyclophosphamide
33. Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor related systemic growth-retarding factors
34. Kinetics of cell proliferation of an experimental tumor
35. Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine
36. Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil
37. Report of the committee on Hodgkin's disease staging classification